Skip to main content
. Author manuscript; available in PMC: 2016 Feb 24.
Published in final edited form as: Eur Spine J. 2015 Mar 8;24(8):1729–1737. doi: 10.1007/s00586-015-3851-z

Figure 2.

Figure 2

A 62-year-old female patient with confirmed pathological diagnosis as tuberculosis. (a) MR T2WI and (b) MR T1WI show steolytic destruction in T7–8 vertebral body. A soft tissue mass compressing the spinal canal is shown and the vertebra disc is affected. (c) and (d) Contrast-enhanced MR T1WI shows a heterogeneously enhanced lesion. (e) The DCE kinetics shows a plateau pattern (approximately 9% increase between the last time point and the estimated 1-min point). In pharmacokinetic analysis, the fitted Ktrans=0.111/min, kep=0.253/min.